Immunotherapeutic approaches for Alzheimer's disease

Neuron
Thomas Wisniewski, Fernando Goñi

Abstract

Alzheimer's disease (AD) is the most prevalent form of dementia worldwide and is an emerging global epidemic. It is characterized by an imbalance between production and clearance of amyloid β (Aβ) and tau proteins. Oligomeric forms of Aβ and tau are believed to be the most toxic. Dramatic results from AD animal models showed great promise for active and passive immune therapies targeting Aβ. However, there is very limited evidence in human studies of the clinical benefits from these approaches. Immunotherapies targeting only tau pathology have had some success but are limited so far to mouse models. The majority of current methods is based on immunological targeting of a self-protein; hence, benefits need to be balanced against risks of stimulating excessive autoimmune toxic inflammation. For greater efficacy the next generation of vaccines needs to focus more on concurrently targeting all the intermediate toxic conformers of oligomeric Aβ and tau species.

References

Mar 29, 2000·JAMA : the Journal of the American Medical Association·J NäslundJ D Buxbaum
Jan 15, 2002·DNA and Cell Biology·C A LemereH L Weiner
May 11, 2005·Neurology·S GilmanUNKNOWN AN1792(QS-21)-201 Study Team
Jun 22, 2005·Cellular and Molecular Life Sciences : CMLS·A RostagnoJ Ghiso
Sep 21, 2006·Brain : a Journal of Neurology·Kazuki TaharaKen-ichiro Fukuchi
Sep 23, 2006·Science·Melanie Meyer-LuehmannMathias Jucker
Oct 13, 2006·Archives of Neurology·Hanna RosenmannOded Abramsky
Dec 16, 2006·Current Alzheimer Research·Mathew Blurton-Jones, Frank M Laferla
Feb 23, 2007·Molecular Biology of the Cell·Amitabha MajumdarFrederick R Maxfield
May 23, 2007·Proceedings of the National Academy of Sciences of the United States of America·Andreas MuhsClaude Nicolau
Aug 24, 2007·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ayodeji A AsuniEinar M Sigurdsson
Feb 26, 2008·Neurobiology of Aging·Norman R RelkinMarc E Weksler
Jun 4, 2008·Journal of Neuropathology and Experimental Neurology·Rudy J CastellaniMark A Smith
Feb 13, 2009·Advanced Drug Delivery Reviews·Jörg Vollmer, Arthur M Krieg
Mar 6, 2009·The Journal of Nutrition, Health & Aging·A SchneebergerW Schmidt
Mar 12, 2009·CNS & Neurological Disorders Drug Targets·Mary P LambertWilliam L Klein
Jun 2, 2009·Current Opinion in Immunology·Rakez Kayed, George R Jackson
Jun 9, 2009·Nature Cell Biology·Florence ClavagueraMarkus Tolnay
Nov 20, 2009·Neurology·S SallowayUNKNOWN Bapineuzumab 201 Clinical Trial Investigators
May 18, 2010·Biochimica Et Biophysica Acta·Thomas Wisniewski, Einar M Sigurdsson
Dec 15, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Allal BoutajangoutEinar M Sigurdsson
Dec 17, 2010·Journal of Internal Medicine·D Morgan
Dec 21, 2010·Acta Neuropathologica·Heiko Braak, Kelly Del Tredici
Feb 24, 2011·The Journal of Biological Chemistry·David T HickmanAndreas Muhs
Mar 23, 2011·Cold Spring Harbor Perspectives in Biology·David W Colby, Stanley B Prusiner
Sep 14, 2011·Archives of Neurology·Thomas S WingoDavid J Cutler
Oct 27, 2011·Annals of Neurology·Mathias Jucker, Lary C Walker

❮ Previous
Next ❯

Citations

Feb 26, 2016·Frontiers in Immunology·Enrica PietronigroGabriela Constantin
Feb 4, 2016·Human Gene Therapy·Sandro AlvesNathalie Cartier
Dec 5, 2015·Nature Reviews. Drug Discovery·Knut BiberMarco Prinz
Feb 24, 2016·Drug Development Research·Michael H IrwinCarl A Pinkert
Feb 18, 2016·Neural Plasticity·Jaume FolchAntoni Camins
Mar 20, 2016·Cellular and Molecular Neurobiology·Edith HamelXin-Kang Tong
Mar 30, 2016·BioDrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy·Genevieve Evin
Jul 30, 2015·Ageing Research Reviews·Lucy Nelson, Naji Tabet
Jul 13, 2016·Journal of Neuroinflammation·Weiguo DongTomomi Kiyota
Jul 17, 2016·Ageing Research Reviews·Santiago Solé-DomènechFrederick R Maxfield
Jul 28, 2016·Journal of the American Medical Directors Association·Rosalie M SternerAimee C Yu Ballard
Oct 31, 2016·Genomics, Proteomics & Bioinformatics·Xing PengHongxing Lei
Oct 19, 2016·Acta Neuropathologica·Asad JanPoul H Sorensen
Jan 4, 2017·Chemical Reviews·Bryan Ronain Smith, Sanjiv Sam Gambhir
Feb 7, 2017·Nature Reviews. Immunology·Adrian Liston, Seth L Masters
Feb 23, 2017·Annual Review of Immunology·Marco Colonna, Oleg Butovsky
Jun 18, 2017·Neurotoxicity Research·Zhong-Yue LvLan Tan
Jan 26, 2017·Médecine sciences : M/S·Aurélien Lathuilière, Bernard L Schneider
Dec 4, 2015·American Journal of Alzheimer's Disease and Other Dementias·Yangjia LuLai Xinsheng
Jan 31, 2018·Proceedings of the National Academy of Sciences of the United States of America·Santiago Solé-DomènechFrederick R Maxfield
Mar 6, 2018·Journal of Alzheimer's Disease : JAD·Pankaj D MehtaDavid L Miller

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Alzheimer's Disease: APOE

Apolipoprotein E (APOE) polymorphic alleles are major genetic risk factors for Alzheimer's disease. Discover the latest research on APOE and other genetic determinants of Alzheimer's disease here.

ApoE Phenotypes

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of Alzheimer's disease and cardiovascular disease. Here is the latest research on APOE phenotypes.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.

Alzheimer's Disease: Tau & TDP-43

Alzheimer's disease is a neurodegenerative disease. This feed focuses on the underlying role of tau proteins and TAR DNA-binding protein 43, as well as other genetic factors, in Alzheimer's disease.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Animal Models

Alzheimer's disease is a neurodegenerative disease which can be studied using various experimental systems. This feed focuses on animal models used for Alzheimer's disease research.

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.

Alzheimer's Disease: Microglia

Microglia are a type of glial cell found throughout the brain and spinal cord. Microglia have been found to be associated with Alzheimer's disease development and progression. Here are the latest discoveries pertaining to Alzheimer's disease and microglia.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Related Papers

Zhongguo xian dai shen jing ji bing za zhi
Priyanka Sabharwal, Thomas Wisniewski
Biochemical Pharmacology
Thomas Wisniewski, Fernando Goñi
The Mount Sinai Journal of Medicine, New York
Thomas Wisniewski, Allal Boutajangout
© 2021 Meta ULC. All rights reserved